MedDataX Logo

Quadratus Lumborum Block by Paraspinous Sagittal Shift Approach With Different Concentrations Of Bupivacaine in Hip Surgeries

NCT ID: NCT04628689

Last Updated: 2020-11-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

5 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-11-20

Study Completion Date

2020-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to evaluate the optimum concentration of bupivacaine in Paraspinous Sagittal Shift Approach for Quadratus Lumborum Block in hip Surgeries

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

With the patient in the lateral decubitus and the block side independent, a curvilinear ultrasound transducer (2-5 MHz) will be directed caudally in a sagittal plane 3-4 cm lateral to the lumbar spinous process of L4, which is almost opposite to the iliac crest, producing a longitudinal scan of the lumbar paravertebral region; and thus identifying the transverse processes of L3 and L4, with PM muscle in-between and erector spinae muscle posteriorly.

The probe is shifted slowly to the lateral side until the transverse processes disappear and the QL muscle is evident in its long axis attached caudally to the iliac crest with a characteristic sonographic image of three muscle layers appearing from posterior to anterior as: erector spinae, QL, and PM muscles respectively. After subcutaneous local infiltration with lidocaine at the cephalic end of the probe, the block needle is advanced in a cephalo-caudal direction, through the erector spinae and QL muscles, until it pierces the epimysium of the QL. LA is injected anterior to the QL muscle, observing its spread in a caudal direction towards the iliac crest between the QL and psoas muscles

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Surgeries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 0.25% bupivacaine

30 ml 0.25% bupivacaine

Group Type ACTIVE_COMPARATOR

quadratus lumborum block by paraspinous sagittal shift approach

Intervention Type OTHER

quadratus lumborum block by paraspinous sagittal shift approach

Group 0.375% bupivacaine

0.375% bupivacaine

Group Type ACTIVE_COMPARATOR

quadratus lumborum block by paraspinous sagittal shift approach

Intervention Type OTHER

quadratus lumborum block by paraspinous sagittal shift approach

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

quadratus lumborum block by paraspinous sagittal shift approach

quadratus lumborum block by paraspinous sagittal shift approach

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA I and II undergoing hip surgery.

Exclusion Criteria

* Contraindications for regional blocks (eg. Patient refusal Infection at the injection site, coagulopathy) allergic reaction to drugs. opium addiction, any drug or substance abuse
Minimum Eligible Age

30 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beni-Suef University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

doaa rashwan

Assistant professor Doaa Rashwan

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Benisuef univercity

Banī Suwayf, Benisuef, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

doaa rashwan

Role: CONTACT

Phone: 00201011270763

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Doaa Rashwan, MD

Role: primary

Samaa Rashwan, MD Rashwan, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FMBSUREC/01092020/Abd El Badei

Identifier Type: -

Identifier Source: org_study_id